Abstract
Presentation given by William Gruber, Senior Vice President Vaccine Clinical R&D Pfizer for the ACIP emergency meeting of December 11th.
Background paper
Americas
United States of America
vaccine safety
vaccine efficacy
Reactogenicity
COVID-19
